Biparametric multicommutated flow analysis system for determination of human serum phosphoesterase activity

•PEDD-based MCFA system for biparametric enzyme assays is developed.•The system is useful for simultaneous ACP and ALP assays.•The system is validated with real human serum samples. A multicommutated flow analysis (MCFA) system constructed of microsolenoid valves and pumps offering simultaneous dete...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Analytica chimica acta 2013-10, Vol.797, p.57-63
Hauptverfasser: Tymecki, Łukasz, Strzelak, Kamil, Koncki, Robert
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•PEDD-based MCFA system for biparametric enzyme assays is developed.•The system is useful for simultaneous ACP and ALP assays.•The system is validated with real human serum samples. A multicommutated flow analysis (MCFA) system constructed of microsolenoid valves and pumps offering simultaneous determination of activity of acid phosphatase (ACP) and alkaline phosphatase (ALP) in human serum samples has been developed. The MCFA system is based on optoelectronic flow-through detector made of two light emitting diodes and operating according to paired emitter detector diode (PEDD) principle. This photometric PEDD device has been dedicated for detection of p-nitrophenol (NP) generated in the course of enzymatic hydrolysis of p-nitrophenyl phosphate and optimized for the determination of NP in human serum samples. The developed PEDD-based MCFA system allows independent optimization of conditions for reaction and detection steps of photometric ACP and ALP bioassays. Moreover, it allows elimination of photometric interferences from serum matrix components according to two-points kinetic mode of measurement. The single measurement cycle takes 12min, consists of four measurements (two for each phosphoesterase) and enables determination of serum ACP and ALP activities at physiological and pathological levels. The real analytical utility of the developed MCFA system has been confirmed by analysis of control sera as well as real human serum samples from healthy persons and oncological patients.
ISSN:0003-2670
1873-4324
DOI:10.1016/j.aca.2013.08.047